Henoch-Schönlein purpura in the setting of COVID-19 infection: Two pediatrics cases and review of the literature
- PMID: 38024921
- PMCID: PMC10657077
- DOI: 10.4103/jfmpc.jfmpc_26_23
Henoch-Schönlein purpura in the setting of COVID-19 infection: Two pediatrics cases and review of the literature
Abstract
Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children, often following a viral infection. Various types of rashes attributed to COVID-19 infection have been described in the literature; however, HSP has rarely been reported. We report two children with HSP associated with acute COVID-19 infection with a review of the available literature. We highlight the clinical presentation, medical management, outcome and age-related difference of reported patients. A limitation of this article is the retrospective nature, limiting full patient history and associated conditions. The findings of this review show that HSP in the setting of COVID-19 is more common in children than adults, with a male predominance, involving various body systems creating a constellation of presentations. Given that HSP can have long-term morbidity from renal disease if untreated, this review may help guide the practitioner's approach to HSP and recognition in the setting of COVID-19 infection.
Keywords: Case report; Henoch–Schönlein purpura; coronavirus disease 2019.
Copyright: © 2023 Journal of Family Medicine and Primary Care.
Conflict of interest statement
There are no conflicts of interest.
Figures



References
-
- Sanchez A, Sohier P, Benghanem S, L'Honneur AS, Rozenberg F, Dupin N, Garel B. Digitate papulosquamous eruption associated with severe acute respiratory syndrome Coronavirus 2 infection. JAMA Dermatol. 2020;156:819–20. - PubMed
-
- Recalcati S. Cutaneous manifestations in COVID-19:A first perspective. J Eur Acad Dermatol Venereol. 2020;34:e212–3. - PubMed
Publication types
LinkOut - more resources
Full Text Sources